Ruling by DC Circuit Court of Appeals Provides CSL the Right to Challenge CBP’s Plasma Ban
Statement attributable to Greg Boss, Executive Vice President - Legal, and CSL Limited Group General Counsel.
CSL Plasma Honored as a South Florida Business Journal 2022 Business of the Year Finalist
CSL Plasma, the plasma collection business of global biotherapeutics leader CSL Behring, has been recognized as a 2022 Business of the Year finalist by the South Florida Business Journal.
CSL Supports Ukrainian Relief Efforts
Aligned with Our Promise to protect human health, CSL is supporting multiple humanitarian relief efforts in the region.
Statement on U.S. FDA Clearance of Plasma Collection Technology in Terumo Blood and Cell Technologies Collaboration with CSL Plasma
CSL Plasma U.S. collection centers are preparing to undergo implementation of newly cleared Rika Plasma Donation System, with limited market release beginning in Colorado centers
CSL Plasma Opens 300th Plasma Donation Center in United States
Greenacres, Florida, center opening exemplifies growing need for plasma donations, which enable production of plasma-derived medicines for patients in 100+ countries
CSL Plasma Provides Free Flu Vaccines for U.S. Plasma Donors
Vouchers enable donors at more than 290 U.S. CSL Plasma donation centers to access free flu shots at Walgreens pharmacy locations
The Colorado Cross-Disability Coalition and CSL Plasma Reach Agreement to Expand Opportunities for People With Disabilities to Donate Plasma
Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform
Plasma is key ingredient for therapies crucial to treating patients affected by life-threatening conditions